Evidence map›Paper›PMID 31448673›Full record

ArticleAutophagy2020

CAV1-CAVIN1-LC3B-mediated autophagy regulates high glucose-stimulated LDL transcytosis.

Xiangli Bai, Xiaoyan Yang, Xiong Jia, Yueguang Rong, Lulu Chen, Tianshu Zeng, Xiuling Deng, Wenjing Li, Guangjie Wu, Ling Wang and 8 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06606821 (The Effects of Tirzepatide on Coronary Plaque Lipid Content and Myocardial Microvascular Function in Overweight and Obese People With Coronary Disease - The IDEAL-COR Study), which is not on this map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06606821 phase4recruitingstarted 2024, after this paper: background citation

The Effects of Tirzepatide on Coronary Plaque Lipid Content and Myocardial Microvascular Function in Overweight and Obese People With Coronary Disease - The IDEAL-COR Study

Ran2024Enrolled124Registered outcomes23Posted comparisons0ConditionsAtherosclerosis Cardiovascular Disease, Chronic Coronary Artery Disease, Coronary Artery Disease, Coronary Microvascular DysfunctionArmsPlacebo, Tirzepatide
Open the trial in the graph
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Male germ cell-specific deletion ofZoological research · 2026
    Article
  7. Role of Caveolae and Caveolin in Vascular Physiology and Pathology.Journal of the American Heart Association · 2026
    Review
  8. Cav-1 deficiency induces cardiac dysfunction via the AdipoR1-AMPK-mTOR autophagy pathway.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Xiangli BaiDepartment of endocrinology, Institute of geriatric medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Xiaoyan YangDepartment of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Xiong JiaDepartment of endocrinology, Institute of geriatric medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Yueguang RongDepartment of Pathogenic biology, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Lulu ChenDepartment of endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Tianshu ZengDepartment of endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Xiuling DengDepartment of endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Wenjing LiDepartment of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Guangjie WuDepartment of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Ling WangDepartment of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Ye LiDepartment of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Jing ZhangDepartment of laboratory medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Zhifan XiongDepartment of endocrinology, Institute of geriatric medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Liang XiongDepartment of laboratory medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Yumei WangDepartment of nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Lin ZhuDepartment of endocrinology, Institute of geriatric medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Ying ZhaoDepartment of endocrinology, Institute of geriatric medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Si JinDepartment of endocrinology, Institute of geriatric medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei, China.
Huazhong University of Science and Technology · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is a recognized high-risk factor for the development of atherosclerosis, in which macroautophagy/autophagy is emerging to play essential roles. The retention of low-density lipoprotein (LDL) particles in subendothelial space following transcytosis across the endothelium is the initial step of atherosclerosis. Here, we identified that high glucose could promote atherosclerosis by stimulating transcytosis of LDL. By inhibiting AMPK-MTOR-PIK3C3 pathway, high glucose suppresses the CAV-CAVIN-LC3B-mediated autophagic degradation of CAV1; therefore, more CAV1 is accumulated in the cytosol and utilized to form more caveolae in the cell membrane and facilitates the LDL transcytosis across endothelial cells. For a proof of concept, higher levels of lipids were accumulated in the subendothelial space of umbilical venous walls from pregnant women with gestational diabetes mellitus (GDM), compared to those of pregnant women without GDM. Our results reveal that high glucose stimulates LDL transcytosis by a novel CAV1-CAVIN1-LC3B signaling-mediated autophagic degradation pathway. ABBREVIATIONS: 3-MA: 3-methyladenine; ACTB: actin beta; AMPK: AMP-activated protein kinase; Bafi: bafilomycin A

Indexed as

AMP-Activated Protein Kinase KinasesAutophagosomesAutophagyCaveolin 1Class III Phosphatidylinositol 3-KinasesEndothelial CellsFemaleGene Knockdown TechniquesGlucoseHumansHuman Umbilical Vein Endothelial CellsLipoproteins, LDLMicroscopy, Electron, TransmissionMicrotubule-Associated ProteinsMutationPregnancyAMP-Activated Protein Kinase KinasesCAV1 protein, humanCaveolin 1CAVIN1 protein, humanClass III Phosphatidylinositol 3-KinasesGlucoseLipoproteins, LDLMAP1LC3B protein, humanMicrotubule-Associated ProteinsProtein KinasesRNA-Binding ProteinsTOR Serine-Threonine KinasesAtherosclerosisautophagyCAV1/caveolin-1caveolae associated protein 1hyperglycemiaLDL transcytosis

Identifiers

PMID31448673
PMCPMC7469686
OpenAlexW2969604259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.